| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.06 |